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Abstract  
To meet the demands of increased global meat consumption, animal production systems will 
have to become more efficient, or at least maintain the current efficiency utilizing feed 
ingredients that are not also used for human consumption.  Use of growth promoters is a 
potential option for increasing production animal feed efficiency and increased muscle 
growth.  The objective of this manuscript is to describe the mechanisms by which the growth 
promoters, beta-adrenergic agonists and growth hormone, mediate their effects, with specific 
consideration of the aspects which have implications for meat quality.   
 
1. Introduction 
The predicted increase in world population to 9 billion by 2050 is expected to be associated 
with an increase in the urban population, with an estimated 70% being in an urban 
environment compared to 49% today and, hopefully, the inevitable increase in incomes (FAO, 
2009).  To meet this demand it is estimated that the food production will have to increase, 
particularly for commodities associated with higher incomes, such as meat, with the predicted 
demand more than doubling by 2050 (FAO, 2009).    
To date, significant advances in animal genetics and animal nutrition have been made to meet 
the increasing demand.  To achieve the maximum growth potential, high quality feed 
ingredients are required. Feed ingredients account for a large proportion of the overall costs of 
animal production, particularly in non-ruminant species (Patience, Rossoni-Serao, & 
Gutierrez, 2015). Continuing to rely on the same ingredients, in competition with human 
nutrition and biofuels, mean prices will inevitably increase.   Therefore the cost of meat and 
animal products will also increase. It has been estimated that for many agricultural 
commodities the rate of production has already reached a peak (Seppelt, Manceur, Liu, 
Fenichel, & Klotz, 2014).  Hence, if we are to continue to meet the demand for animal 
products, we cannot simply feed more animals the same feed ingredients, as that would 
require more crops, land and water (Foresight, 2011; Godfray et al., 2010).  Therefore the aim 
of current research is to improve the efficiency with which animals utilise their feeds, giving 
more product for the same amount of feed or the same amount of product for less feed.  
Through selective breeding and improved diet formulations over the last 20-30 years, feed 
efficiency of pigs (Patience et al., 2015) and chickens (Siegel, 2014) has improved, with Feed 
Conversion Ratio (FCR) values of 2.0 or less currently achievable (i.e. >50% efficiency).   
The UN suggests productivity is likely to be enhanced in the future through better animal 
disease control, improved irrigation and water management practices, and better fertilizers 
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(FAO, 2009). In terms of animal production the increase in productivity could also be 
increased through the continued utilization of genetic selection through breeding programmes.  
Also it is probably inevitable that molecular biology technologies will be accepted and GMO 
organisms will be utilized for animal production.  However throughout the world there is an 
increasing utilization of growth promoters. A goal of all these technologies is to increase the 
efficiency of feed utilization that ideally results in an increase in lean carcass weight.  A 
predominant group of growth promoters are those which are based on endocrine factors such 
as anabolic steroids, growth hormone (GH, also called somatotropin, ST) and beta-adrenergic 
agonists (BA).  These agents have metabolic modifying characteristics that result in enhanced 
growth.  In addition there are a variety of other types of growth promoters, such as antibiotics, 
whose predominant affect is thought to be the increased efficiency of utilization of nutrients 
from the gut.   Although the use of growth promoting agents is banned in the European Union 
(EU), they are legally used in many other countries. 
Increases in lean tissue deposition (increased muscle mass), decreases in fat deposition, along 
with repartitioning nutrients away from fat to muscle growth, are some of the predominant 
objectives of animal production systems focused on generating meat. Therefore these are key 
features of animal growth that growth promoters are designed to influence.  The actions of 
hormonal based growth promoters’ are through mechanisms that influence processes at a 
cellular level.  In addition to affecting protein turnover to increase protein accretion, they also 
have effects on energy metabolism.  This manuscript will examine the effects of hormonal 
based growth promoters on carcass parameters that influence meat quality, particularly 
growth hormone (GH) and beta-adrenergic agonists (BA), and will predominantly focus on 
their effects in pigs. 
 
2. Growth Hormone  
Growth hormone is a peptide hormone produced by the anterior pituitary and is involved in 
the processes of development and growth that includes skeletal muscle, bone and adipose 
tissue (Beermann, 1994).  Increased plasma GH has the effect of redirecting nutrients away 
from adipose tissue and toward muscle and bone   (Etherton & Bauman, 1998).  The effect of 
GH is to stimulate the production of insulin like growth factor (IGF-1) from the liver.  These 
observations led to the hypothesis that GH effects, particularly on growth, were mediated by 
IGF-1 originating from the liver (Daughaday, 2000). However GH can stimulate IGF-1 
expression in other tissues, particularly bone but also skeletal muscle (Brameld et al., 1996; 
Velloso, 2008: Wang, Bikle & Chang, 2013).  In the circulation IGF-1 is associated with 
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insulin like growth factor binding proteins (IGFBP) which prolong its half-life (Boisclair, 
Rhoads, Ueki, Wang, & Ooi, 2001). The effect of IGF-1 can be mediated through dimers of 
the IGF-1 receptor as well as IGF-1 receptor/insulin receptor hybrids (Denley, Cosgrove, 
Booker, Wallace, & Forbes, 2005) and subsequently activates multiple signalling pathways.  
In muscle the predominant pathways are the mitogen-activated protein kinase 
kinase/extracellular signal-regulated kinase (MEK/ERK pathway, which tends to be 
associated with proliferative growth, whilst the protein kinase B -mechanistic target of 
rapamycin - ribosomal protein S6 kinase (Akt–mTOR–S6K) pathway is predominantly 
responsible for protein synthesis but also affects protein degradation (Clemmons, 2009).  
Growth Hormone is approved for use in 14  countries, including Australia, for administration 
to pigs to improve growth characteristics (Dunshea, Cox, Borg, Sillence, & Harris, 2002).  As 
the GH is a peptide it has to be administered by regular injection.  Its action on pig growth has 
been well characterised, reducing feed intake whilst simultaneously increasing lean and 
reducing fat deposition (Etherton et al., 1987).  Unsurprisingly, due to the signalling pathway 
activated by GH-IGF-1 axis, increased protein accretion in GH treated pigs is stimulated by 
protein synthesis rather than a decrease in protein degradation.  However there are 
inconsistent reports in the literature with some reporting similar increases in protein synthesis 
and breakdown but overall net increased nitrogen balance (Tomas et al., 1992), whilst others 
have reported that protein synthesis is increased but protein degradation appears not to be 
affected (Bush et al., 2003) and some have described even a decrease in degradation (Vann et 
al., 2000).  The effect of exogenous GH on adipose tissue is to reduce fat synthesis which 
results in reductions in back fat (Krick et al., 1992).   Dunshea et al. (2005) carried out a 
comprehensive review on the effects of GH on pig meat quality.  Using a meta-analysis 
approach on published data, they concluded that GH decreased intramuscular fat by 12% and 
increased shear force by 9%.  The effects on shear force are unlikely to be due to a large 
decrease in the proteolytic activity.  Therefore the increased shear force is likely to be due to 
changes in temperature transfer to the meat, either during chilling the carcass, thereby 
affecting rigor development or effects of heat transfer during cooking which influences 
denaturing of proteins.    Overall Dunshea et al. (2005) concluded that GH causes a small 
increase in shear force and the sensory perception of meat from treated pigs is tough, but it 
was unlikely that that this could be detected by consumers (Dunshea, D’Souza, Pethic, 
Harper, & Warner,  2005) 
 
3. Beta-adrenergic agonists 
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The BAs are analogues of the endogenous catecholamines, adrenaline and noradrenaline.  
When administered to livestock species they have positive effects on growth and nutrient 
repartitioning.  Beta-2 adrenergic receptor specific agonists, such as clenbuterol and 
cimaterol, have the greatest growth effect; however ractopamine, which binds to both beta-1 
and -2 adrenergic receptors (Mills, Kissel, Bidwell, & Smith, 2003), also has similar growth 
effects.  The BA generally have positive effects on weight gain, FCR, and act as strong 
repartitioning agents, increasing muscle growth whilst decreasing adipose tissue deposition 
(Meersman, 1998). 
The BAs mediate their growth effects through the BA receptor. The subtypes of beta 
adrenergic receptors (BAR) vary depending on the tissue.  For example, in pigs skeletal 
muscle has more BAR2 than BAR1 whilst in adipose tissue it is the reverse (Liang & Mills, 
2002).  BAR3 are thought to be present on porcine adipocytes (McNeel & Mersmann, 1995).  
The BAR activates the adenylate cyclase pathway which subsequently produces cyclic 
adenosine monophosphate (cAMP), which then activates protein kinase A.   This kinase can 
alter enzyme activity through phosphorylation.  For example the phosphorylation dependent 
cascade results in phosphorylase being activated and glycogen being degraded to glucose-1-
phosphate.  In addition, protein kinase A can activate the transcription factor, cAMP response 
element binding protein (CREB), which then regulates the transcription of genes that have a 
functional cAMP responsive element within their regulatory regions (Altarejos & Montminy, 
2011).  Therefore these agents have an immediate effect on enzyme activity, but can also alter 
transcription of a number of genes.  
The first BA to be licensed for use as a feed additive was ractopamine for use in pigs in 1999.   
A significant advantage of these agents when compared to GH is that they can be 
administered in feed.  The predominant effect of BA is to increase lean deposition whilst also 
decreasing fat deposition (Meersman, 1998). The BAs have strong effects on muscle 
hypertrophy and appear to be differentially effective across farm species, with ruminant 
species (cattle and sheep) responding the strongest, being particularly effective in older 
animals (Meersman, 1998).    The early studies on the effects of BA in livestock indicated that 
these agents had a strong effect of decreasing protein degradation without increasing protein 
synthesis (Bohorov, Buttery, Correia, & Soar, 1987). However subsequent studies in pigs 
treated with ractopamine have indicated that protein synthesis, particularly of myofibrillar 
proteins, is stimulated (Adeola, Ball, & Young, 1992).   The effects on fat deposition are not 
as clear as for GH, particularly in pigs, however it appears that ractopamine reduces backfat 
thickness in pigs, but this is not as dramatic as the effect of BA in ruminant species (Dunshea 
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et al., 2005).   After reviewing a large number of studies, Dunshea et al. (2005) concluded that 
the use of BA in ruminants increased the shear force, with cimaterol increasing shear force by 
60%.  Using a meta-analysis approach on published data they also described how, in pigs, the 
BAs ractopamine and salbuterol had no effect on IMF, whilst cimaterol caused a decrease. All 
these BA had the effect of increasing shear force in pigs, but again cimaterol had the greatest 
negative effect, but the effects were not as great as in ruminants. Unlike GH, the effect of BA 
on tenderness appears to be mediated through their strong inhibitory effects on protein 
degradation (see below), rather than effects on IMF.   
 
4. Fibre type and meat quality  
Skeletal muscle is made up of muscle fibres which have differing contractile and metabolic 
characteristics.  Muscle fibres can be histochemically classified according to their actomyosin 
ATPase activity into three types, types I, IIA and IB, which have a contractile and associated 
metabolic characteristics of slow twitch oxidative, fast twitch oxidative and fast twitch 
glycolytic, respectively (Brooke & Kaiser, 1970).  When considered at a molecular level the 
differences in fibre type are, in part, determined by the myosin heavy chains (MyHC) they 
express, as this protein is a determinant of muscle contractile speed and thereby the associated 
metabolism required to support this.  There are four MyHC isoforms (types I, IIa, IIx and IIb) 
which has led to a revision in the classification of fibre types as types I, IIA, IIX and IIB with 
a rank order of contraction speed of I<IIA<IIX<IIB (Schiaffino & Reggiani, 1996).  The 
MyHCIIb isoform is expressed in rodents, but absent from most large animals such as cattle 
and sheep, although pigs do express this isoform (Lefaucheur, 2009).  To support the 
contraction of these fibres there are associated metabolic characteristics.  At one extreme, the 
slow twitch fibres that express high levels of MyHCI protein have a dependence on oxidative 
(aerobic) metabolism, as they can maintain a low power output.  These fibres have a good 
blood supply and tend to have a low glycogen and high triglyceride content and fatigue 
slowly, so are used for sustained contraction.  In contrast, the fast twitch type II fibres have a 
dependence on glycolytic (anaerobic) metabolism. These fibres have a relatively low blood 
supply and have a high glycogen content and low triglyceride content and fatigue relatively 
quickly so are used for rapid, intense contraction, which cannot be sustained for long periods. 
The type IIB fibres have the highest glycolytic metabolism capacity.  The type IIA and IIX 
fibres have metabolic characteristics that, although still enable a high degree of glycolytic 
metabolism, increasingly have the capacity to carry out oxidative metabolism, hence they are 
classified as oxidative-glycolytic, particularly the type IIA fibres which have the greatest 
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aerobic capacity (Schiaffino & Reggiani, 1996). For glycolytic fibres (type IIA, IIX and IIB) 
there is not a simple relationship between the expression of the fast MyHC protein isoforms 
(IIa, IIx and IIb) and the fibre type classification based on contractile and metabolic 
characteristics.  For example in Large White pig longissimus muscle, fibres classified as type 
IIB included MyHC IIx expressing fibres, as well as hybrid fibres expressing both MyHC IIx 
and IIb (Lefuacher, 2009). These hybrid fibres are a particular characteristic of the fast 
glycolytic fibres, which means using MyHC expression data to determine fibre type (as 
normally defined by contractile and metabolic characteristics), should be done with caution.       
 Based on the association between the metabolic characteristics of muscle and fibre 
type, it would be expected that IMF content would be lower in muscles that contain a high 
proportion of fast fibre types, particularly those containing a high proportion of type IIB 
fibres, for example in pigs.  Recent work in pigs has indicated no clear relationship between 
proportions of type I and IIB fibres and IMF content (Kim et al., 2013), although the total 
number of fibres and density of type IIB fibres were positively related to the IMF content 
(Kim et al., 2013).  Henckel et al. (1997) made a similar observation in pigs, that the 
frequency of type IIB fibres was positively correlated to IMF.  However those who have 
reviewed this area have concluded that there does not appear to be a clear relationship 
between the quantity of intramuscular adipocytes and fibre type (Lefaucheur, 2009; Hocquette 
et al., 2010).   In relation to the metabolic activity of type IIB fibres, these fast-twitch 
glycolytic fibres have a higher dependence on glycolytic metabolism, therefore they have 
higher glycogen contents.   As a result, muscles that have a high proportion of these types of 
fibres tend to have an increased rate of postmortem pH decline, along with a lower ultimate 
pH, as well as decreased water holding capacity and a paler colour (Choe et al., 2008; Larzul 
et al., 1997; Ryu & Kim, 2005).   The fast type fibres have greater cross sectional areas (CSA) 
than the slow fibres, with the type IIB fibres having the greatest CSA.  However muscles 
containing fibres with a high CSA have been reported as having a lower meat quality in both 
cattle (Renand et al., 2001) and pigs (Karlsson et al., 1993;  Kim,  et al., 2013).   However the 
relationship between CSA per se and meat quality is not absolutely clear. Studies that have 
reported this relationship have often done so in animals that have variant genes or are subject 
to growth promoter treatments, which show a change in CSA, but this is associated with 
alterations in metabolic activity (Lefaucheur, 2009). For example, although callipyge lambs 
do have fibres with a large CSA, their muscles contain very high concentrations of 
calpastatin, which is thought to be a more significant factor in causing their extreme 
toughness (Duckett, Snowder, & Cockett, 2000).     
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5. Proteolytic systems and meat quality  
The final tenderness of meat depends on the degree of alteration of the muscle structural and 
associated proteins postmortem (Hopkins & Thompson, 2002). Specific myofibrillar, 
myofibril cytoskeleton and costamere proteins are subjected to cleavage, with selected and 
restricted cleavage of the major myofibrillar proteins such as actin and myosin (Goll, 
Thompson, Taylor, & Christiansen, 1992; Taylor, Geesink, Thompson, Koohmaraie, & Goll, 
1995a; Lametsch et al., 2003).  There are several endogenous proteolytic systems present in 
muscle, which could participate in postmortem proteolysis, these include the cathepsin, 
proteasome, caspase and calpain systems (Kemp, Sensky, Bardsley, Buttery, & Parr, 2010).   
Generally it is considered that the cathepsin system does not play a role in meat tenderisation, 
as there is little association between cathepsin activity and the variation in the tenderness of 
meat (Whipple et al., 1990).   
The proteasome is a multicatalytic protease complex involved in the regulation of a number of 
basic cellular pathways, by their degradation of proteins in the cytosol and nucleus (Coux, 
Tanaka, & Goldberg, 1996).  Proteolysis by the proteasome is an ubiquitin-dependent 
process; poly-ubiquitinated proteins are subsequently recognised by the proteasome, which 
then degrades them (Taillandier et al., 2004).  This process is ATP-dependent requiring a 
number of enzymes to ubiquitinate target proteins.  In muscle there are ubiquitin system 
ligases which appear to be critical to the proteasomes involvement in protein degradation.  
These are muscle RING finger 1 (MuRF1) and muscle atrophy F-box (MAFbx) (Bodine & 
Baehr, 2014.).   These ligases are strongly associated with muscle atrophy conditions (Glass, 
2005).   Although in vivo the proteasome requires ATP for target proteins to be ubiquitinated, 
the proteasome can carry out protoeolytic activity without requiring ATP or ubiquitin (Peters, 
Franke, & Kleinschmidt, 1994). Indeed proteasome activity is maintained during the 
postmortem conditioning period, with reported substantial activity still detectable at 7 days 
postmortem and at pH levels of less than 6 (Lamare, Taylor, Farout, Briand, & Briand, 2002). 
Taylor et al. (1995b) and Robert et al. (1999) found that the proteasome was capable of 
causing proteolysis of myofibril proteins including nebulin, myosin, actin and tropomyosin in 
bovine myofibrils. However, as emphasized by Koohmaraie and Geesink (2006), the 
degradation pattern of myofibrillar proteins in incubations with proteasome are not the same 
as that seen in postmortem muscle, although this does not appear to exclude the proteasome 
from making a contribution to the process of postmortem proteolysis (Houbak, Ertbjerg, & 
Therkildsen, 2008). 
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The caspase system is involved in the process of programmed cell death (apoptosis).   The 
system consists of a number of enzymes whose substrates include cytoskeletal proteins which 
are degraded both in apoptosis and in postmortem muscle. It has been proposed that the 
protease family of caspases could be active postmortem and contribute to tenderization 
(Sentandreu, Coulis, & Ouali, 2002; Ouali et al., 2006, Kemp et al., 2010; Kemp & Parr, 
2012). Of particular interest are the effector caspases, such as caspase 3 and 7, which are 
activated by upstream initiator caspases, such as caspase 9, and once activated target and 
cleave specific substrates, resulting in cell disassembly (Fuentes-Prior & Salvesen, 2004).  
There have been descriptions of caspase activity as well as cleavage of indicative caspase 
substrates which are associated with meat tenderization, including potential effects on the 
calpain inhibitor, calpastatin (Kemp & Parr, 2012).  However others have reported no changes 
in caspase activity postmortem, suggesting a lack of involvement in tenderization 
(Underwood, Means, & Du, 2008), whilst others have indicated associations between caspase 
activity and myofibril protein degradation as well as postmortem proteolysis (Huang, Huang,  
Xu, & Zhou, 2008; Huang, Huang, Zhou, Xu, & Xue, 2011).   However whether this 
proteolytic system plays a major role in influencing tenderness is debatable.  If it does have a 
role in the postmortem proteolysis which influences meat tenderness, it is likely to be 
contributory rather than causative. 
Of all the proteolytic systems the calpain system is the one which has the strongest 
experimental evidence demonstrating a role in post-mortem proteolysis (Kemp et al., 2010; 
Koohmaraie & Geesink, 2006; Sentandreu et al., 2002).  In skeletal muscle, the calpain 
system consists of three proteases, ubiquitously expressed isoforms Calpain-1, Calpain-2, and 
p94 (or Calpain-3) and the calpain-specific endogenous inhibitor, calpastatin (Goll, 
Thompson, Li, Wei, & Cong, 2003; Wendt, Thompson, & Goll, 2004).   Experimental 
evidence suggests Calpain-1 has the most significant role in postmortem proteolysis and meat 
tenderisation.  Much of this evidence has been based on observations on the association 
between Calpain-1 activity, as well as expression, to tenderness (Koohmaraie & Geesink, 
2006).  The important role of Calpain-1 in the tenderisation process was further strengthened 
by observations made in calpain-1 knockout mice, which indicate a direct effect of Calpain-1 
in postmortem proteolysis and thereby the development of tender meat (Geesink, Kuchay, 
Chishti, & Koohmaraie, 2006). A consistent observation of the calpain system’s involvement 
in tenderness is that high levels of calpastatin are associated with poor quality meat; the 
model being that high levels of calpastatin reduce the activity of calpain (predominantly 
Calpain-1) thereby reducing the proteolysis required for tender meat (Kemp et al., 2010).   
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Changing animal nutrition has been shown to alter calpain expression and is associated with 
changes in meat quality.  In pigs, a moderate reduction in both protein (14.95% vs 11.08%) 
and digestible energy (13.81MJ vs 12.55MJ) intake has been shown to attenuate expression of 
Calpain-1 mRNA and this was associated with decreased Warner-Bratzler shear force (Tang 
et al., 2010).  However, much earlier studies in lambs found that a more severe reduction in 
feed intake over 6 weeks (so average daily live weight gain was 14% of controls), did not 
alter calpain or calpastatin activity (Higgins, Lasslett, Bardsley, & Buttery, 1988). Changes in 
the calpain system activity have also been described associated with increased feed efficiency. 
Pigs selected for low residual feed intake (RFI), where their observed feed intake is lower 
than expected (based on body weight gain and back fat depth), have reduced protein 
degradation compared to those with high RFI (Cruzen et al., 2013).  Relative to high RFI 
pigs, low RFI animals had lower proteasome activity, greater calpastatin activity and 
decreased Calpain-1:calpastatin activity ratio.  These changes were associated with slowed 
postmortem muscle proteolysis, indicated by decreased Troponin T degradation.  This study 
is consistent in showing that a decrease in the proteolytic process and subsequent reduction in 
meat tenderness is predominantly associated with increased inhibition of calpains.  In 
addition, this study suggests that if increased feed efficiency is achieved by a decrease in 
protein degradation, this could have a detrimental effect on meat quality. 
Our studies on a random selection of commercially slaughtered pigs have shown that a high 
level of calpastatin (both activity and protein levels) in the first few hours after slaughter are 
associated with an increased incidence of toughness at 8 days postmortem (Sensky et al., 
1998; Parr et al., 1999).  The observations that Calpain-1 and calpastatin are important 
determinants for tender meat has lead to efforts to identify genetic markers that could be used 
to select for postmortem tenderisation of meat.  Genetic tests for variation in both the 
Calpain-1 (CAPN1) and calpastatin (CAST) genes, which are associated with tenderness, 
have been identified for cattle (Page et al., 2004; White et al., 2005; Casas et al., 2006).   In 
pigs, similar efforts have identified genetic markers for CAST which have been suggested to 
be markers of pork meat quality traits (Ciobanu et al., 2004, Nonneman et al., 2011), but as 
yet predictive variations in CAPN1 have not been reported. 
 
6. Effects of BA and GH on fibre type, proteolytic systems and metabolism.    
The objective of administration of the growth promoters is to ideally increase feed efficiency 
but at the same time increase lean tissue deposition (increase muscle mass) and decrease fat 
deposition, thereby repartitioning nutrients away from fat to muscle growth.   Given that post-
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natal muscle growth involves hypertrophy rather than hyperplasia it might be expected that 
stimulated growth would result in increased muscle fibre hypertrophy.   Of the growth 
promoters BA and GH, the former has the strongest muscle growth effects. Both BA and GH 
have been shown to increase muscle fibre hypertrophy (Kim & Sainz, 1992), but to a more 
limited extent for GH (Solomon, Campbell, & Steele, 1990).  In GH treated animals there 
appears to be no effect on fibre type distribution and this is particularly the case for pigs 
(Aalhus, Best, Costello, & Schaefer, 1997; Oksbjerg et al., 1995).  However for animals 
treated with BA there are well documented effects on fibre type distributions.  Early studies in 
lambs indicated that the BA cimaterol (10ppm, oral dose, for 5 weeks) caused an increase in 
type II fibres compared to type I (Beermann et al., 1987).  In pigs treated over a four week 
period with the BA, ractopamine (20ppm, oral dose), there was a sustained induction of 
MyHCIIb in longissimus muscle (Gunawan, Richert, Schinckel, Grant, & Gerrard, 2007).   
This change in gene expression takes place early in the treatment, within one day for 
MyHCIIb.  Likewise in pigs following seven days of treatment with ractopamine (10ppm, 
oral dose), in longissimus muscle there was a trend for MyHCIIb mRNA to increase and for 
MyHCIIa mRNA to decrease  (Brown, Ryan, Daniel, Mareko, Parr, & Brameld, 2012) and 
this was before a significant increase in muscle weights was observed (Ryan, Daniel, Mareko, 
Brown, Parr, & Brameld, 2012).   In the same study, pigs were also treated with GH for seven 
days (10mg/pig, intramuscular injection every 2 days).  There was a trend for decrease in 
MyHCIIb gene expression in muscles with GH, but no indication of changes in muscle 
weights (Brown et al., 2012).  Similarly in lambs, following a six day treatment with 
cimaterol (10ppm, oral dose), there was a decrease in MyHCIIa isoform gene expression and 
an increase in MyHCIIx/b, which consisted of an induction of  MyHCIIb, a MyHC not 
normally expressed  in sheep muscles (Hemmings, Daniel, Buttery, Parr, & Brameld, 2015). 
This switch to fast MyHC gene expression was accompanied by an increase in selective 
muscle weights and CSA (unpublished observations).   It was interesting to note that although 
MyHC gene expression was altered after six days, the quantity of MyHC protein did not 
change (Hemmings et al., 2015).  However there was a decrease in isocitrate dehydrogenase 
activity which suggested that there was a change to a less oxidative metabolism, before there 
was a change in the contractile proteins associated with a fast-glycolytic fibre type 
(Hemmings et al., 2015).      
The net deposition of protein often results in an increase in protein synthesis, however 
alterations in protein degradation can also take place.   Growth hormone stimulated increases 
in IGF-1 potentially mediates its effects through MEK/ERK and Akt–mTOR–S6K pathways.   
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Although IGF-1 stimulated protein synthesis can be influenced by both pathways, the effect 
of IGF-1 on protein degradation is mediated by the latter.  The Akt–mTOR–S6K pathway 
also controls protein degradation in skeletal muscle by AKT phosphorylating the forkhead 
box protein (FOXO) transcription factors, thereby reducing the gene expression of the 
ubquitin ligases MAFbx and MuRF1 (Glass, 2005).  These two ubiquitin ligases are important 
in muscle protein turnover, as they target myofibrillar proteins for degradation through the 
ubiquitin-proteasome system (Bodine & Baehr, 2014).    
For BA, early reports on the mechanism of its action described how clenbuterol treatment for 
five weeks (10ppm, oral dose) significantly reduced muscle protein degradation in lambs  
(Bohorov et al., 1987), although subsequent studies have shown BA also stimulate protein 
synthesis, for example in pigs given ractopamine for four weeks  (20ppm, oral dose)  (Adeola 
et al., 1992).  The characteristic effect of orally administered BA such as clenbuterol or 
cimaterol on protein degradation is an increase in the expression and activity of calpastatin 
(Higgins et al., 1988; Parr, Bardsley, Gilmour, & Buttery, 1992).   This observation has been 
confirmed by others, particularly in ruminants (Kretchmar, Hathaway, Epley, & Dayton, 
1990; Wheeler & Koohmaraie, 1992), but also in pigs (Parr, Sensky, Bardsley, & Buttery, 
2001). In a more recent study, Douillard et al. (2012) described how over expression of 
exogenous calpastatin in mouse tibialis anterior attenuated the muscle hypertrophy and the 
shift to a fast muscle fibre type, stimulated by clenbuterol treatment for 21 days 
(subcutaneous injection, 1mg/kg body weight/day).  This was in spite of AKT and associated 
factors being phosphorylated, an event which is normally associated with increased muscle 
synthesis.  The authors suggested that inhibition of clenbuterol stimulated hypertrophy by 
calpastatin over-expression did not involve inhibition of protein synthesis.  They also 
suggested that the exogenous calpastatin expression inhibited calpain’s role in remodeling the 
muscle myofibrillar proteins.  Care must be taken in accepting this interpretation, as Douillard 
et al. (2012) described how in control mice treated with only clenbuterol for 21 days 
(subcutaneous injection, 1mg/kg body weight/day) there was decreased calpastatin 
expression.  This contradicts previous studies in rodents which have shown BA increases 
calpastatin in mice treated with formoterol for 28 days (intraperitoneal injection, 
100microg/kg body weight/day) (Koopman et al., 2010) and rats treated with clenbuterol for 3 
days (intraperitoneal injection,  3mg/kg body weight/day) (Gonçalves et al., 2011).  Overall 
the majority of studies demonstrate treatment with BA increases muscle calpastatin.   The 
effect of BA on normal muscle is to enhance protein synthesis and reduce calcium–dependent 
proteolysis, which appears to be mediated through an increase in calpastatin.   However in 
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mice with denervated muscle, which induces atrophy, treatment with clenbuterol for 3 days 
(intraperitoneal injection, 3mg/kg body weight/day) stimulated protein synthesis and inhibited 
the proteolysis mediated by both the proteasome and lysosome, reduced expression of the 
ubiquitin ligases, MAFbx and MuRF1, as well as cathepsin L, without a significant effect on 
calcium dependent proteolysis (Gonçalves et al., 2011).   This suggests that the calpain 
system mediated proteolysis is associated more with normal muscle protein turnover, rather 
than that associated with atrophy  
 Our recent studies have sought to examine the effects of GH or BA treatment on muscle 
proteolytic systems.  In pigs treated with either ractopamine (20ppm, oral dose) or GH 
(10mg/pig, intramuscular injection every 2 days) for 27 days there was a significant effect of 
this BA on muscle weights and this was associated with a switch to increased expression of 
the MyHC isoforms associated with fast fibre types, whereas there was no effect of GH 
(Brameld et al., 2015).  In terms of effects on meat quality, there was an indication of an 
increase in shear force in BA treated animals (P = 0.107).  There was a trend (P < 0.1) for 
increased calpastatin protein (detected by western blot) in BA treated animals, but there was 
no effect on caspase 3/7 activity (when assessing activity these two caspases are 
indistinguishable) (Mareko, Ryan, Brown, Brameld, & Parr, 2013a).  When proteasome 
activity was assessed there was a change in the activity of its subunits; these have trypsin-like, 
caspase-like and chymotrypsin-like activity.  When these activities were assessed 
individually, the caspase-like activity was significantly reduced in both BA and GH treated 
pigs, and the chymotrypsin-like activity was increased in BA treated animals only (Mareko, 
Ryan, Brown, Brameld, & Parr, 2013b).   Overall these data would suggest that the effect of 
the BA ractopamine on muscle proteolysis is not as great as some of the other BAs used in 
earlier studies, particularly cimaterol and clenbuterol.   
In addition to examining changes in proteolytic activity in pigs  treated with the GH 
(10mg/pig, intramuscular injection every 2 days) and ractopamine (20ppm, oral dose) for 27 
days, we also examined the effect of these growth promoters on gene expression in the 
Longissimus muscle at days 1, 3, 7, 13 and 27 of treatment.  The changes in the transcriptome 
were measured using a pig transcriptome microarray.  Although our previous studies had 
indicated stimulatory effects of BAs on the gene expression of the calpain system in pigs, 
particularly increases in calpastatin gene expression (Parr et al., 2001), we found no consistent 
significant effects on gene expression of any major proteolytic system in muscle across the 
time course.  However as might have been expected, the greatest gene expression responses 
were seen with ractopamine treatment.   There was an increase in the expression of genes 
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encoding glycolysis enzymes but a decreased expression of genes associated with oxidative 
respiration.   However the most predominant effect was a co-ordinate increase in serine 
synthesis pathway gene expression, with increased expression of phosphoglycerate 
dehydrogenase (PHGDH), phosphoserine-aminotransferase (PSAT) and phosphoserine 
phosphatase (PSPH).  This was confirmed at the protein level, as PHGDH was significantly 
increased with BA (Brameld et al., 2015).  As had been observed in the past, BA had a 
stronger muscle hypertrophic effect than GH.  The effects of ractopamine on proteolytic 
systems do not appear to be as potent as previous described for the standard beta-2 agonists, 
such as cimaterol and clenbuterol.  However, ractopamine does appear to be mediating its 
effect on muscle in pigs through biosynthetic pathways. 
 
7. Conclusion 
The consumption of meat as a protein source is predicted to increase dramatically in the next 
few decades.  This requirement along with the increasing pressure of feed availability will 
demand that animal production systems are efficient.   To achieve this it is very likely that the 
use of growth promoters will increase, as well as the possible use of genetically modified 
organisms.   The current licensed growth promoters, which have direct effects on muscle 
growth as well as fat deposition, were discovered over 30 years ago.  Although their effects 
on meat quality tend to be negative, they do not appear, at least in pigs, to have such drastic 
effects which cause a significant number of consumers to perceive poor meat quality.  
However it is likely there will be an increased incentive to develop new types of growth 
promoters. Fast glycolytic fibres appear to be the most receptive to growth stimuli whilst slow 
aerobic fibres appear to be relatively resistant to anabolic stimuli.   One of the major 
limitations of muscle growth is that fibre number is essentially fixed at birth for most species, 
which means post-natal anabolic agents mediate their effects via hypertrophy.  One of the 
consequences of hypertrophy is oxygen becomes less available, therefore glycolytic 
dependent metabolism becomes more favourable.   Care has to be taken to ensure new types 
of growth promoters do not target mechanisms which result in increased CSA of fast 
glycolytic fibres and significant decreases in protein degradation (proteolytic systems), as 
there is then likely to be a significant decline in meat quality.   
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